Loading clinical trials...
Loading clinical trials...
First Line Infusional 5-Fluorouracil, Folinic Acid and Oxaliplatin for Metastatic Colorectal Cancer or Loco-Regional Recurrency - Role of Chronomodulated Delivery Upon Survival - A Multicenter Randomized Phase III Trial
Conditions
Interventions
FOLFOX regimen
fluorouracil
+2 more
Locations
36
Austria
Krankenanstalt Rudolfstiftung
Vienna (Wien), Austria
VZW Monica Campus Eewnfeestkliniek
Antwerp, Belgium
Hopital Saint Jean
Brussels, Belgium
Cliniques Universitaires Saint-Luc
Brussels (Bruxelles), Belgium
Centre Hospitalier Notre Dame - Reine Fabiola
Charleroi, Belgium
Les Cliniques Saint-Joseph ASBL
Liege (Luik), Belgium
Start Date
March 1, 1998
Primary Completion Date
March 1, 2002
Last Updated
July 2, 2012
NCT04704661
NCT06696768
NCT05489211
NCT06625775
NCT04657068
NCT06607458
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions